PTGS2 and cancer: In particular, Guanosine 2',3'-cyclic phosphate demonstrated exceptional binding activity to multiple docked target proteins, exhibiting the strongest binding affinity to PTGS2 (-14.1 kcal/mol), suggesting its potential significance in cancer therapy.